Hexagon Nutrition Board Approves Q1 FY27 Results, Declares 30 Paise Dividend
Hexagon Nutrition Limited's Board approved Q1 FY27 unaudited financial results. A final dividend of ₹0.30 per share is recommended for FY26, with September 15, 2026, as the record date. The 33rd AGM is scheduled for September 22, 2026. Remuneration for key directors was revised, and Mr. Raghunath Sawant appointed as Additional Executive Director.
The declaration of dividend and approval of financial results are material information for investors. Changes in directorship and remuneration also have a moderate impact on corporate governance perception.
The company reported its quarterly results and recommended a dividend, which are generally positive events for shareholders. The appointment of new directors and revision of remuneration also indicate active management.
Hexagon Nutrition Limited announced the outcome of its Board Meeting held on August 12, 2026. The Board approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, along with the limited review report from the statutory auditors.
The company will convene its 33rd Annual General Meeting (AGM) on Tuesday, September 22, 2026, at 11:30 a.m. through Video Conferencing (VC)/Other Audio-Visual Means (OAVM). The book closure for the AGM will be from September 16, 2026, to September 22, 2026.
A final dividend of ₹0.30 Paise per equity share of face value ₹1 each for the financial year ended March 31, 2026, has been recommended. The record date for determining eligibility for this dividend is fixed as Tuesday, September 15, 2026. The dividend is subject to declaration by the members at the AGM.
Furthermore, the Board approved revisions in the annual remuneration for Chairman and Executive Director Mr. Arun Purushottam Kelkar, Managing Director Mr. Vikram Arun Kelkar, and Joint Managing Director Dr. Nikhil Arun Kelkar, subject to member approval at the AGM. The re-appointment of Mr. Arun Purushottam Kelkar as Chairman & Director was also recommended, pending member approval.
Mr. Raghunath Sawant has been appointed as an Additional Executive Director effective August 12, 2026. The Board also approved the alteration of the Articles of Association, subject to member approval, and the dissolution of the IPO Committee following the successful completion of the IPO.
The trading window for all directors, promoters, connected persons, designated persons, and their immediate relatives will open 48 hours after the declaration of the financial results for the quarter ended June 30, 2026.
What to do with a filing like this
Hexagon Nutrition Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Hexagon Nutrition Limited. Read the original for the full detail.